Three important components of the psychiatric interview are the establishment of rapport and the therapeutic alliance, the history of present illness (HPI), and the mental status examination (MSE). Building rapport through active listening, empathy, and open-ended questions fosters a safe, trusting environment that encourages patients to share sensitive information (Roberts & Hilty, 2019). This is essential because many individuals with psychiatric concerns face stigma or mistrust, and a strong therapeutic alliance enhances engagement, treatment adherence, and diagnostic accuracy. The HPI offers a detailed, chronological narrative of the current episode—including onset, duration, severity, triggers, and functional impairment—which forms the foundation for accurate differential diagnosis and individualized treatment planning. The MSE provides a structured, objective assessment of the patient’s current mental state across domains such as appearance, behavior, speech, mood, affect, thought process and content, cognition, insight, and judgment. Together, these components integrate subjective patient narratives with observable clinical data, supporting holistic, patient-centered psychiatric care (Roberts & Hilty, 2019).

The rating scale assigned is the Generalized Anxiety Disorder 7-item (GAD-7) scale. This brief self-report tool demonstrates strong psychometric properties. It exhibits excellent internal consistency, with Cronbach’s alpha coefficients typically ranging from 0.89 to 0.93. It also shows good test-retest reliability and robust construct validity, supported by a unidimensional factor structure (Johnson et al., 2019). Criterion validity is strong, with a cutoff score of 10 or higher providing approximately 89% sensitivity and 82% specificity for detecting generalized anxiety disorder, while correlating well with other validated anxiety and depression measures. These properties hold across diverse populations, including primary care and psychiatric settings (Spitzer et al., 2006; Johnson et al., 2019).

The GAD-7 is appropriate for use during the psychiatric interview when screening for or monitoring anxiety symptoms in adults and adolescents (generally age 13 and older), particularly during initial evaluations, follow-up visits, or when patients endorse worry, restlessness, or somatic symptoms suggestive of anxiety disorders. It is especially valuable in time-constrained outpatient or PMHNP settings as a quick, standardized tool. For nurse practitioners, the GAD-7 quantifies symptom severity (minimal, mild, moderate, severe), supports diagnostic formulation, tracks treatment response (e.g., to SSRIs), informs shared decision-making, and aligns with measurement-based care principles to optimize outcomes (Spitzer et al., 2006). Evidence-based literature underscores its role in improving recognition of anxiety, guiding evidence-based interventions, and addressing care gaps in underserved populations (Johnson et al., 2019) The Psychiatric Evaluation and Evidence-Based Rating Scales.

References

Johnson, S. U., Ulvenes, P. G., Øktedalen, T., & Hoffart, A. (2019). Psychometric properties of the General Anxiety Disorder 7-item (GAD-7) scale in a heterogeneous psychiatric sample. Frontiers in Psychology, 10, Article 1713. https://doi.org/10.3389/fpsyg.2019.01713Links to an external site.

Roberts, L. W., & Hilty, D. M. (Eds.). (2019). Handbook of psychiatric education (2nd ed.). American Psychiatric Association Publishing.

Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092Links to an external site.

The Psychiatric Evaluation and Evidence-Based Rating Scales 

The psychiatric evaluation is a comprehensive process that enables mental health providers to assess a client’s emotional, cognitive, and behavioral functioning. Information obtained during the psychiatric interview is essential for establishing an accurate diagnosis, developing an individualized treatment plan, and evaluating treatment outcomes. Three particularly important components of the psychiatric interview include rapport building, obtaining a comprehensive psychiatric history, and conducting the mental status examination (MSE). 

Establishing rapport is a critical first step in the psychiatric interview because it creates a therapeutic environment in which clients feel comfortable discussing sensitive information. A strong therapeutic alliance promotes trust, facilitates honest communication, and improves treatment engagement and adherence (Hartley et al., 2020). Without rapport, clients may be reluctant to disclose symptoms, traumatic experiences, substance use concerns, or safety issues that are necessary for accurate assessment and diagnosis. 

Obtaining a comprehensive psychiatric history is equally important because it provides contextual information regarding the client’s current symptoms and overall functioning. This assessment includes psychiatric, medical, substance use, family, developmental, and social histories. Collecting this information allows clinicians to identify contributing factors, recognize patterns of illness, and differentiate among potential diagnoses (Raeburn et al., 2023). A thorough psychiatric history also supports the development of individualized treatment plans that address the client’s unique needs and circumstances. 

Another essential component of the psychiatric interview is the mental status examination (MSE). The MSE provides a structured assessment of a client’s appearance, behavior, speech, mood, affect, thought processes, thought content, cognition, insight, and judgment. Because it evaluates a client’s current psychological functioning in real time, the MSE offers valuable information that assists clinicians in identifying psychiatric symptoms, assessing safety risks, and formulating differential diagnoses (Hartley et al., 2020). 

The PHQ-9 is a standardized self-report instrument designed to screen for depression, assess symptom severity, and monitor treatment response. The PHQ-9 demonstrates strong psychometric properties, including excellent internal consistency (Cronbach’s α ≈ 0.89), good sensitivity, and good specificity for identifying depressive symptoms across diverse patient populations (Hong et al., 2021). These characteristics support the reliability and validity of the instrument in both primary care and psychiatric settings. 

The PHQ-9 is appropriate for use during initial psychiatric evaluations and follow-up appointments. During an initial assessment, the tool assists clinicians in identifying depressive symptoms and determining their severity. During ongoing treatment, repeated administration of the PHQ-9 provides an objective method for monitoring symptom changes and evaluating treatment effectiveness. For psychiatric nurse practitioners, the PHQ-9 supports measurement-based care by providing quantifiable data that can guide clinical decision-making, treatment adjustments, and outcome evaluation (Hong et al., 2021). Although the PHQ-9 is a valuable screening instrument, its results should be interpreted in conjunction with clinical judgment, diagnostic interviews, and additional assessment findings because screening scores alone are insufficient to establish a psychiatric diagnosis (Levis et al., 2020). 

Overall, rapport building, obtaining a comprehensive psychiatric history, and conducting the mental status examination serve as foundational components of the psychiatric interview. When combined with evidence-based rating scales such as the PHQ-9, these assessment strategies enhance diagnostic accuracy, support treatment planning, and contribute to improved mental health outcomes for clients. 

References 

Hartley, S., Raphael, J., Lovell, K., & Berry, K. (2020). Effective nurse-patient relationships in mental health care: A systematic review of interventions to improve the therapeutic alliance. International Journal of Nursing Studies, 102, 103490. https://doi.org/10.1016/j.ijnurstu.2019.103490Links to an external site. 

Hong, R. H., Murphy, J. K., Michalak, E. E., Chakrabarty, T., Wang, Z., Parikh, S. V., Culpepper, L., Yatham, L. N., Lam, R. W., & Chen, J. (2021). Implementing measurement-based care for depression: Practical solutions for psychiatrists and primary care physicians. Neuropsychiatric Disease and Treatment, 17, 79–90. https://doi.org/10.2147/NDT.S283731Links to an external site. 

Levis, B., Benedetti, A., Ioannidis, J. P. A., Sun, Y., Negeri, Z., He, C., Wu, Y., Krishnan, A., Bhandari, P. M., Neupane, D., Imran, M., Rice, D. B., Riehm, K. E., Saadat, N., Azar, M., Boruff, J., Cuijpers, P., Gilbody, S., Kloda, L. A., & McMillan, D. (2020). Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: Individual participant data meta-analysis. Journal of Clinical Epidemiology, 122, 115–128.e1. https://doi.org/10.1016/j.jclinepi.2020.02.002Links to an external site. 

Raeburn, T., Bradshaw, J., & Cleary, M. (2023). Mental health history—It matters. Issues in Mental Health Nursing, 44(1), 3–5. https://doi.org/10.1080/01612840.2022.2138437Links to an external site. 

The Psychiatric Evaluation and Evidence-Based Rating Scales Discussion 1

I  am intentionally approaching this discussion not merely to fulfill a grading rubric, but I am taking the opportunity to increase  knowledge and retention. I am actively learning to transition from a general nursing perspective to an advanced practice framework, where the psychiatric interview becomes a structured process for collecting clinical data, developing differential diagnoses, and creating evidence-based treatment plans. To accomplish this I have decided to analyze a fictional patient.  This is a 24 YO male presenting with a three week history of severe functional impairment following a relationship breakup. He presents with a slumped posture, delayed speech responses, poor eye contact, and reports feeling “completely empty and worthless”.

The first component of the psychiatric interview is to obtain a thorough History of Present Illness (HPI). The HPI is the basis for diagnostic reasoning and it explores eight elements that can be adapted from physical to psychiatric documentation by using emotional, behavioral, and situational descriptions.

• Location: Area of concern (mood, thought process, perception).
• Quality: Descriptive manifestations (depressed)
• Severity: Intensity or clinical impact (controlled, uncontrolled).
• Timing: Temporal patterns or situational triggers ( time of day, specific situations).
• Duration: Onset and persistence of symptoms.
• Context: Influencing psychosocial factors.
• Modifying Factors: Triggers or alleviating strategies.
• Associated Symptoms: Related functional disturbances ( appetite, weight, libido) (Aapc, 2013)

The interview includes assessment of mood, sleep pattern, appetite, energy level, concentration, and ability to perform activities of daily living.  The patient reported a persistent sadness, loss of interest in previously enjoyable activities, “really bad insomnia”  characterized by waking early each morning, decreased appetite resulting in a 12 pound weight loss, fatigue, impaired concentration, and pervasive feelings of worthlessness. These symptoms lead to “I am unable to complete tasks at work and I am not able to socialize like I did before”.  These symptoms were systematically  compared against the DSM -5- TR diagnostic criteria, and maps directly. The DSM -5 requires 5/9 symptoms  during the same 2 week period. There should also be a main symptom such as depressive disorder. The patient is demonstrating a depressed mood and anhedonia. These are two  hallmarks of Major Depressive Disorder (MDD) (American Psychiatric Association [APA], 2022).  These symptoms have persisted for more than 2 weeks and are causing cognitive and functional  impairment MDD  becomes a primary diagnostic consideration (APA, 2022).

The second component  of the psychiatric interview is the Mental Status Exam:  The HPI consists of the patient’s subjective experience, the MSE provides objective clinical observations regarding current psychological functioning. During the assessment, the patient appears disheveled with poor grooming and hygiene. He moves and speaks quite slowly, often taking a long time to answer (psychomotor retardation).  His mood is described as “empty,” while his affect is constricted and congruent with his reported emotional state. Thought processes remain logical and goal-directed but noticeably slowed. Thought content reveals excessive self-blame and feelings of failure. He denies hallucinations, delusions, and other psychotic symptoms. Cognition is  intact, and he is alert and oriented to person, place, time, and situation. Insight and judgment are fair.  He presents with symptoms that describe his level of functioning and some safety concerns (Voss & Das, 2024).

Third Component of the Psychiatric Interview

This is the most important component of the interview which is a comprehensive suicide assessment. The association between depressive disorders and suicide risk requires that the clinician asks direct questions regarding suicidal thoughts. This is a clinical and ethical necessity (Substance Abuse and Mental Health Services Administration [SAMHSA], 2024) .

Assess passive and active suicidal ideation, intent, planning, previous attempts, access to lethal means, and protective factors. When asked directly, the patient reports occasional thoughts that life may not be worth living and admits that he has wondered whether others would be better off without him. However, he denies a specific suicide plan or intent. He identifies his mother and younger sister as being available and supportive and expresses a desire to improve despite feeling overwhelmed. Although the patient does not appear to be at imminent risk for self-harm, his presentation warrants the development of a safety plan, provision of crisis resources, and close monitoring (SAMHSA, 2020) The Psychiatric Evaluation and Evidence-Based Rating Scales.

The development of a differential diagnosis is important and Major Depressive Disorder seems most likely, other possibilities should be considered. Adjustment Disorder with Depressed Mood remains a potential diagnosis because symptoms developed following a significant emotional stressor. Bipolar disorder must also be ruled out by assessing for a history of manic or hypomanic episodes. Substance-induced depressive disorders, trauma-related disorders, and medical conditions such as hypothyroidism should likewise be considered before confirming a definitive diagnosis.

To strengthen the diagnosis and in order to lean towards accuracy and supporting measurement-based care, the Patient Health Questionnaire-9 (PHQ-9) should be administered. The PHQ-9 is an important tool because each of its nine items corresponds to one of the nine DSM-5-TR symptoms of depression (Kroenke et al., 2001). A  PHQ-9 score of 19 would place the patient within the moderately severe depression category. This tool provides a standardized baseline measure of symptom burden and severity (Levis et al., 2019).   The PHQ-9 has demonstrated strong reliability and validity and is widely used in psychiatric practice to monitor treatment outcomes and symptom progression (Levis et al., 2019). Integrating the PH-Q 9 into clinical practice guides  decision making and improves patient  outcomes. It is a common quality measure for commercial payors and medicaid and meets the psychosocial risk assessment for a wellness visit The Psychiatric Evaluation and Evidence-Based Rating Scales.

One major strength of the PHQ-9 is its strong psychometric performance. Research demonstrates high reliability, strong internal consistency, and good sensitivity and specificity for identifying major depression (Levis et al., 2019). The instrument is brief, easy to administer, free of charge, and can be completed within minutes. These characteristics make it practical in busy outpatient psychiatric settings. It is useful in measurement-based care, which refers to the systematic use of symptom-rating scales to guide clinical decision-making.

The second major purpose of the PHQ-9 is measuring treatment response over time. In psychotherapy, repeated administration of the PHQ-9 allows clinicians to objectively monitor symptom improvement. For example, if the patient’s score decreases from 19 to 10 after several weeks of treatment, this change would indicate meaningful clinical improvement. Additionally, persistently elevated scores may indicate the need for treatment modifications, additional interventions, or reassessment of the diagnosis. The PHQ-9 functions as a clinical outcome measure rather than solely a screening tool.

The limitations  of the PHQ-9 tool:  It is a self-reporting tool and responses may be influenced by social bias, limited insight, literacy challenges, or misunderstanding of questions. The tool should not replace a comprehensive psychiatric interview, diagnostic evaluation, or clinical judgment. Additionally, while the PHQ-9 identifies depressive symptom severity, it does not differentiate Major Depressive Disorder from bipolar depression, adjustment disorders, or depressive symptoms related to medical conditions. Therefore, findings must always be interpreted within the context of a comprehensive psychiatric assessment.

From a PMHNP perspective, the greatest value of the PHQ-9 lies in its ability to bridge diagnosis and treatment evaluation. It assists clinicians in identifying depressive

This patient is slumping low in his chair, his appearance is unkempt.  He tells you he feels empty because his relationship ended. As a nurse practitioner, you use the PHQ-9 to get a baseline score. He scores a 19, meaning his depression is moderately severe. But the tool has real limits. It cannot tell you why he is depressed. Is this a situational adjustment, the low phase of bipolar disorder, or a thyroid issue? The paper can’t tell you that. Only your clinical interview and lab work can.

The real power of the PHQ-9 is how it bridges your assessment directly into his actual psychotherapy. When you look closely at his answers, you see he scored a maximum 3 on guilt and feeling like a failure.  When he comes back in a month feeling discouraged, you can pull out the scale again. If his score dropped from a 19 to a 13, you can show him the hard data. He can see how he is doing The Psychiatric Evaluation and Evidence-Based Rating Scales.

Finally, it acts as your ultimate safety net. If he marks a 2 or a 3 on Item 9 for thoughts of death, you stop the routine paperwork immediately. You pivot and work with him right then and there to build a safety plan and keep him safe. That is how a simple tool becomes a dynamic, living part of your care.

Patient Health Questionnaire-9 (PHQ-9)

Instructions: Over the last 2 weeks, how often have you been bothered by any of the following problems? (Scoring: Not at all = 0, Several days = 1, More than half the days = 2, Nearly every day = 3)

• Item 1. Little interest or pleasure in doing things (Core Symptom)
• Item 2. Feeling down, depressed, or hopeless (Core Symptom)
• Item 3. Trouble falling or staying asleep, or sleeping too much
• Item 4. Feeling tired or having little energy
• Item 9. Thoughts that you would be better off dead, or of hurting yourself in some way

Total Score Severity Ranges:

• 0 to 4: Minimal Depression
• 5 to 9: Mild Depression
• 10 to 14: Moderate Depression
• 15 to 19: Moderately Severe Depression
• 20 to 27: Severe Depression
• The Psychiatric Evaluation and Evidence-Based Rating Scales

References

Aapc, A. (2013, August 1). Successfully capture HPI elements in psychiatry E/M notes. AAPC Knowledge Center. https://www.aapc.com/blog/25848-successfully-capture-hpi-elements-in-psychiatry-em-notes/?srsltid=AfmBOoom9W6oP25-4EW3SUe8XlVfXg0vyLcYO2J0uF9XYQRvOUu73Wd6

Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). (2022). American Psychiatric Association. https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425787

Kroenke, K., Spitzer, R., & Williams, J. (2001). The PHQ-9: Validity of a brief depression severity measure.

Levis, B., Benedetti, A., & Thombs, B. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. https://www.bmj.com/content/bmj/365/bmj.l1476.full.pdf

Substance Abuse and Mental Health Services Administration [SAMHSA]. (2024). SAFE-T Five-Step evaluation and triage. https://library.samhsa.gov/sites/default/files/safet-flyer-pep24-01-036.pdf

Voss, & Das. (2024, April 30). Mental status examination – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK546682/f The Psychiatric Evaluation and Evidence-Based Rating Scales